Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
Conditions:   Inflammatory Bowel Diseases;   Ulcerative Colitis;   Crohn Disease;   Microbiome Intervention:   Sponsors:   Chinese University of Hong Kong;   National Taiwan University;   Hanoi Medical University;   Mahidol University;   Indonesia University;   National University of Malaysia;   Kiang Wu Hospital;   National Academy of Medical Sciences, Nepal;   Duke-NUS Graduate Medica l School;   National University Hospital, Singapore;   Heidelberg University;   University of Chicago;   Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2022 Category: Research Source Type: clinical trials